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Mutations in Leucine-Rich Repeat Kinase-2 (LRRK2) result in familial Parkinson’s disease
and the G2019S mutation alone accounts for up to 30% in some ethnicities. Despite
this, the function of LRRK2 is largely undetermined although evidence suggests roles in
phosphorylation, protein interactions, autophagy and endocytosis. Emerging reports link
loss of LRRK2 to altered synaptic transmission, but the effects of the G2019S mutation
upon synaptic release in mammalian neurons are unknown. To assess wild type and
mutant LRRK2 in established neuronal networks, we conducted immunocytochemical,
electrophysiological and biochemical characterization of >3 week old cortical cultures of
LRRK2 knock-out, wild-type overexpressing and G2019S knock-in mice. Synaptic release
and synapse numbers were grossly normal in LRRK2 knock-out cells, but discretely
reduced glutamatergic activity and reduced synaptic protein levels were observed.
Conversely, synapse density was modestly but significantly increased in wild-type LRRK2
overexpressing cultures although event frequency was not. In knock-in cultures, glutamate
release was markedly elevated, in the absence of any change to synapse density,
indicating that physiological levels of G2019S LRRK2 elevate probability of release. Several
pre-synaptic regulatory proteins shown by others to interact with LRRK2 were expressed
at normal levels in knock-in cultures; however, synapsin 1 phosphorylation was significantly
reduced. Thus, perturbations to the pre-synaptic release machinery and elevated synaptic
transmission are early neuronal effects of LRRK2 G2019S. Furthermore, the comparison
of knock-in and overexpressing cultures suggests that one copy of the G2019S mutation
has a more pronounced effect than an ∼3-fold increase in LRRK2 protein. Mutant-induced
increases in transmission may convey additional stressors to neuronal physiology that may
eventually contribute to the pathogenesis of Parkinson’s disease.
Keywords: LRRK2, LRRK2 mutation, G2019S, Parkinson disease, electrophysiology, cortical culture, transgenic
mice
INTRODUCTION
Despite intense research efforts in the context of Parkinson’s dis-
ease (PD), the basic neurophysiology of LRRK2 remains largely
unknown. Progress is possibly confounded by numerous poten-
tial roles, resulting from LRRK2 being a large multi-domain
protein containing ROC, COR, kinase, WD40, and leucine-rich
repeats (Cookson, 2010). Roc and COR domains are characteris-
tic of the Ras/GTPase (ROCO) signal transductase superfamily,
involved in cytoskeleton reorganization and membrane traffic
(Mizuno-Yamasaki et al., 2012). Evidence suggests LRRK2 kinase
substrates include tau (Kawakami et al., 2012), endophilin A
(Matta et al., 2012), 4E-BP (Lee et al., 2010, 2012) and LRRK2
itself; autophosphorylation regulates its GTPase and kinase
activities (Webber et al., 2011). There is consensus between sev-
eral neuronal culture studies regarding LRRK2-dependent neu-
ritic regeneration phenotypes; axon/dendrite outgrowth are most
often exaggerated by LRRK2 loss and retarded by mutant over-
expression (MacLeod et al., 2006; Plowey et al., 2008; Parisiadou
et al., 2009; Dachsel et al., 2010; Lee et al., 2010; Lin et al., 2010;
Chan et al., 2011; Ramonet et al., 2011; Winner et al., 2011;
Kawakami et al., 2012). However, others have found that neu-
rite phenotypes are robust only during the first week in vitro
(Sepulveda et al., 2013). Comparatively little LRRK2 is expressed
during this period, whereas LRRK2 levels ∼double between the
first and second week, both in vitro and in vivo (Biskup et al.,
2007; Piccoli et al., 2011), during which time glutamatergic
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synaptogenesis and synapse maturation occur. In light of this, we
sought to investigate LRRK2 manipulations in relatively mature
neuronal networks containing functional glutamatergic synapses
(>18 days in vitro; DIV18).
Synaptic transmission and LRRK2 have been studied at the
Drosophila neuromuscular junction where LRRK2 loss results in
synaptic bouton overgrowth, and overexpression has the opposite
effect (Lee et al., 2010) leading to exaggerated phosphorylation
of the vesicle cycle regulator endophilin A (endoA), impaired
endocytosis and a reduced capacity for repeated synaptic release
(Matta et al., 2012). LRRK2 binds several synaptic vesicle cycle
proteins, including adaptor proteins 1 and 2, alpha-actinin 2,
the clathrin coat assembly protein AP180, synapsin 1, VAMP2,
SNAP25, dynamin 1 and synaptophysin (Piccoli et al., 2011,
2014). In cultured cortical neurons, acute RNAi knock-down of
LRRK2 increases glutamatergic release probability (Pr), vesicle
motility and recycling (Piccoli et al., 2011); conversely decreased
glutamate release is reported in LRRK2 KO mouse pups at post-
natal day 15 (Parisiadou et al., 2014). The reports of knock-down
and KO in mammalian cortical neurons and brain slices sug-
gest that LRRK2 acts at the synaptic terminal altering glutamate
release (Piccoli et al., 2011; Parisiadou et al., 2014); however, the
fact that these reports are directly contradictory necessitates fur-
ther examination. Here we aimed to investigate LRRK2 synaptic
physiology in the context of loss of function and gain of function,
against which to compare and contrast LRRK2 mutant effects.
The data presented here are, to the best of our knowledge, the first
investigation of glutamatergic transmission in primary neuronal
cultures derived from LRRK2 transgenic overexpressing (OE),
knock-out (KO) and knock-in (KI) mice.
We found that LRRK2 levels differentially regulate glutamater-
gic synapse density and activity in neuronal cultures from KO and
OE mice. Furthermore, glutamate release was increased, and pre-
synaptic regulatory protein chemistry was disturbed, in cortical
neurons from KI mice. The data demonstrate that endogenous
expression of the most common known genetic cause of PD
has marked effects upon neuronal physiology. Such neuronal
dysfunction, manifested as increased activity, may place an exces-
sive demand upon the neuronal network that may eventually
contribute to the pathogenesis of PD.
EXPERIMENTAL METHODS
TRANSGENIC MICE AND CULTURE PREPARATION
Non-transgenic littermate (NT) C57BL/6J mice and transgenic
human wild-type LRRK2 BAC overexpressing (OE) (Melrose
et al., 2010), knock-out (KO) (Hinkle et al., 2012) and G2019S
knock-in (KI) mice were maintained according to Canadian
Council on Animal Care regulations. KI mice were generated by
inserting a floxed PGK neomycin (PGK-neo) cassette between
murine LRRK2 exons 41 and 42, using C57BL/6 genomic DNA
template. In this process the targeting 5′ homology arm replaced
two nucleotides c.6055G>A & c.6057G>C (numbered from the
ATG start codon of mouse reference sequence NM_025730).
Hence, the native nucleotide sequence of murine exon 41 GAC
TAC GGG ATC GCA (encoding -DYGIA-) was mutated to GAC
TAC AGC ATC GCA (mutated nucleotides underlined; encod-
ing -DYSIA-) to encode the p.G2019S pathogenic substitution.
Targeting, ES clone selection, blastocyst injection and breeding
of ES cell chimeras was performed to obtain germline trans-
mission by Ozgene Pty Ltd. (www.ozgene.com). The PGK-neo
cassette was removed by crossing with Cre-deletor mice and the
Cre transgene was removed in subsequent breeding. The constitu-
tive KI animals have subsequently been maintained on C57BL/6J
stock (>10 generations). Heterozygote (HET) KO × HET KO
breeds yielded homozygous KO and NT pups, HET OE × NT
yielded HET OE pups and NT littermates. HET KI × HET KI
breeds yielded homozygous, heterozygous KI and NT littermates.
Primary neuronal cultures were prepared from timed pregnancy
dames from background strain C57BL/6 mice with the aforemen-
tioned transgenic crosses. Tails from each embryo were genotyped
during the single-pup neuronal isolation, before cells were pooled
by genotype and plated. Only heterozygous KI mice that faithfully
reproduce the human condition were included and are herein
referred to as KI. Cultures were prepared as previously described
(Milnerwood et al., 2012); briefly, cortical neurons were isolated
from pups at E16.5, brains were removed and placed on ice in
Hank’s Balanced Salt Solution (HBSS, GIBCO). 24-well plates
were seeded at 115 k cells/well in 1ml plating medium (PM,
2% B27+1/100 penicillin/streptomycin, Invitrogen; 0.5mM α-
glutamine; neurobasal medium, GIBCO). From DIV4, 10% of
media was added every 3–5 days.
IMMUNOSTAINING AND IMAGE ANALYSIS
For immunocytochemistry DIV21-26 cells were fixed in 4%
paraformaldehyde (PFA) + 4% sucrose for 10min then per-
meabilized with methanol (3min at −20◦C), and blocked (3 ×
20min washes of 10% normal goat serum, NGS, in PBS). Primary
antibodies were incubated overnight with agitation at 4◦C in
PBST plus 2% NGS before blocking again (10% NGS+PBS)
for 1 h at RT, then applying secondary antibody (in PBST +
2% NGS) for 0.5 h (incubated at RT for 1 h, then washed
3× with PBST before 1.5 h at RT with secondary antibodies
(α-mouse Alexa-488, α-rabbit Alexa 568, α-guinea pig Alexa
633 and α-chicken AMCA from Molecular probes and Jackson
Laboratories). Primary antibodies were α-microtubule associ-
ated protein 2 (MAP2, chicken, abcam, ab5392, 1:2500), α-post-
synaptic density protein 95 (PSD-95, mouse, Thermo Scientific,
MA1045, 1:1000), α-vesicular glutamate transporter 1 (VGLUT1,
guinea pig, Chemicon, AB 5905, 1:4000) and α-synapsin1
(Synapsin1, rabbit, Millipore, ab1543p, 1:500). Coverslips were
slide mounted with fluoromount (SouthernBiotech) and all
images were acquired on an Olympus Fluoview 1000 confo-
cal microscope as 0.4μm z-stacks at 60× magnification (flat-
tened with the max projection function for cluster analysis)
and at 40× for cell density counts. Single 60× images (clus-
ter analyses) or mosaics of 40× images were used for anal-
yses. Excitation and acquisition parameters were constrained
across all paired (culture) acquisitions. For co-localization anal-
ysis, stacks in all three channels contained all visible dendritic
MAP2 staining and images were manually thresholded and bina-
rised with experimenter blind, and quantification was conducted
on masked dendritic image fields (MAP2 was expanded 5 pix-
els to catch pre-synaptic elements). Cluster colocalization was
calculated as percentage of PSD95 clusters overlapping with
Frontiers in Cellular Neuroscience www.frontiersin.org September 2014 | Volume 8 | Article 301 | 2
Beccano-Kelly et al. Mutant LRRK2 alters glutamate release
VGluT1 clusters in Cell Profiler (analysis pipelines available
on request) and data expressed as mean ± s.e.m., where n
is average per image field (5–15 images per culture) from a
minimum of 3 independent cultures (culture n in brackets).
For neuronal densities, soma counts (by MAP2) were manually
produced with experimenter blind to genotype on 5–6 image
fields from a minimum of 3 independent cultures (culture n in
brackets).
ELECTROPHYSIOLOGY
Whole-cell patch-clamp recordings were performed on cortical
cells at DIV21–26 in voltage clamp at Vh −70mV and the mem-
brane test function was used to determine intrinsic membrane
properties ∼1min after obtaining whole-cell configuration, as
described previously (Tapia et al., 2011; Kaufman et al., 2012;
Milnerwood et al., 2012; Brigidi et al., 2014). Briefly, neurons were
perfused at room temperature with extracellular solution (ECS)
containing (in mM unless stated): 167 NaCl, 2.4 KCl, 1 MgCl2,
10 glucose, 10 HEPES, 2 CaCl2, pH 7.4, 300 mOsm. Tetrodotoxin
(TTX, 0.2μM), and picrotoxin (PTX, 100μM, except when ana-
lyzing GABA currents) were added before use. Pipette resistance
(Rp) was 3–6 M when filled with (in mM): 130 Cs methanesul-
fonate, 5 CsCl, 4 NaCl, 1 MgCl2, 5 EGTA, 10 HEPES, 5 QX-314,
0.5 GTP, 10 Na2-phosphocreatine, and 5 MgATP, 0.1 spermine,
pH 7.2, 290 mOsm. Data were acquired by Multiclamp 700 B
amplifier and signals were filtered at 2 kHz, digitized at 10 kHz,
and analyzed in Clampfit10 (Molecular Devices). Tolerance for
series resistance (Rs) was<25 M and uncompensated; Rs tol-
erance cut-off was <10%. mEPSCs and mIPSCs were analyzed
with experimenter blind to genotype using Clampfit10 (threshold
5pA mEPSC, 10pA mIPSC); all events were checked by eye and
monophasic events were used for amplitude and decay kinetics,
while others were suppressed but included in frequency counts,
as in Tapia et al. (2011), Kaufman et al. (2012), Milnerwood et al.
(2012), Brigidi et al. (2014). Data are presented as mean ± s.e.m.
where n is cells from a minimum of 3 separate cultures (culture n
in brackets).
WESTERN BLOT
Cultures were scraped from individual coverslips at DIV21 in
100μl of LDS loading buffer (Life Technologies). 15μl of lysate
was resolved using SDS-PAGE on a NuPage 4–12% Bis-Tris gel
(Life technologies) and transferred onto a PVDF membrane
(Millipore) at 25V for 100min at room temperature. Membranes
were incubated overnight in 2% BSA/TBST with the following
primary antibodies; α-Endophilin A (EndoA, mouse, Thermo
Scientific, WH0006456M1, 1:1000), α-vesicle associated mem-
brane protein 1 (VAMP1, rabbit, Synaptic Systems, 104 002,
1:2500), α-vesicle associated membrane protein 2 (VAMP2, rab-
bit, Synaptic Systems, 104 202, 1:2500), α-synaptojanin 1 (SynJ1,
rabbit, Synaptic Systems, 145 003, 1:1000), α-dynamin 1 (DNM1,
rabbit, Thermo Scientific, PA1-660, 1:1000), α-synapsin 1 (rab-
bit, Millipore, AB1543P, 1:5000), α-phophoserine 9 synapsin 1
(rabbit, Thermo Scientific, PA1-4604, 1:2500), α-phosphoserine
603 synapsin 1 (rabbit, Cell Signaling, 2311, 1:2500). Secondary
antibodies (HRP conjugated α-mouse and α-rabbit, Santa Cruz
Biotechnology) were used at 1:5000. BIO-RAD ChemiDoc™ MP
Imaging System was used to detect the signal, which was quanti-
fied using inbuilt Image Lab software (Bio-Rad).
PROTEINSIMPLE©WESTERN ANALYSIS
Protein levels were quantified using an automated capillary-
based size sorting system (O’Neill et al., 2006), “WES” from
ProteinSimple. All procedures were performed with manufac-
turers reagents according to the user manual. Briefly, 8μL
of cell lysate was mixed with 2μL of 5× fluorescent mas-
ter mix and heated at 95◦C for 5min. The samples, blocking
reagent, wash buffer, primary antibodies, secondary antibod-
ies, and chemiluminescent substrate were dispensed into desig-
nated wells in the manufacturer provided microplate. Following
plate loading the separation and immunodetection was per-
formed automatically using default settings. The data was ana-
lyzed with inbuilt Compass software (Proteinsimple). Primary
antibodies used were α-synapsin 1 (rabbit, Millipore, AB1543P,
1:7500), α-phosphoserine 603 synapsin 1 (rabbit, Cell Signaling,
2311, 1:2500), and α-glyceraldehyde 3-phosphate dehydrogenase
(GAPDH, rabbit, Cell Signaling, 2118S).
STATISTICAL ANALYSES
Analyses were performed using Prism6 software (Graphpad,
Inc.). Direct comparisons were made by Student’s t-test (2- tailed,
herein t-test) andmultiple comparisons by appropriate analysis of
variance (ANOVA) and post-tests as detailed in the text.
RESULTS
LRRK WILD TYPE, OVEREXPRESSION AND G2019S MUTANT LEVELS IN
CORTICAL NEURON CULTURES
As LRRK2 is implicated in PD, a disease characterized by nigros-
triatal dysfunction, we concluded it would be appropriate to study
LRRK2’s synaptic activity in cortical cells (CTX) given their input
into the striatum is modulated by nigrostriatal dopamine.
Similarly to increases previously reported in whole-brain lysate
(Biskup et al., 2007), western blotting for LRRK2 protein showed
that levels increase rapidly during the 2nd and 3rd postnatal
week in the cortex of non-transgenic (NT) mice (Figure 1A). We
observed that this pattern is preserved in primary neuronal cul-
tures of CTX cells over the first 3 weeks in vitro (Figure 1A), in
agreement with others (Piccoli et al., 2011). As LRRK2 protein
levels are relatively low over the first week, and because neurite
phenotypes may be lost by the second week in vitro (Sepulveda
et al., 2013), we decided to investigate the effects of LRRK2
manipulations upon synaptic function in neuronal networks of
cortical cultures aged >21DIV. LRRK2 is absent in cortical tissue
from LRRK2 knock out (KO) mice (Figure 1B) and LRRK2 levels
are 2–3-fold increased in human wild-type LRRK2 overexpress-
ing (OE) mouse cortex (p = 0.04) and this pattern is maintained
in cortical cell cultures (Figure 1B). In order to study the effects of
LRRK2mutations in a genetically and physiologically appropriate
manner, we generated G2019S knock-in (KI) mice (Figure 1C).
Founders were backcrossed onto our in-house strain >20 gener-
ations and, as predicted from similar lines (Herzig et al., 2011);
our LRRK2 KI mice are viable, healthy and breed well. Successful
mutation of the endogenous mouse LRRK2 gene, by insertion
and subsequent removal of the cassette, results in a slightly longer
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FIGURE 1 | Age-dependent LRRK2 expression in vivo and in vitro and
generation of LRRK2 G2019S knock-in mice. (A) Representative western
blots showing LRRK2 expression at embryonic day 16 (E16) that increases over
postnatal days 7-21 (P7-21) in mouse cortex (CTX). Positive control lysate from
non-transgenic (NT) P7 CTX was used as a protein standard (STD). A similar
pattern of increasing LRRK2 expression is observed in primary neuronal
cultures frommouse CTX from 1 to 21 days in vitro (DIV). Semi-quantitative
analysis expressed as LRRK2 relative to Grb2 loading control demonstrates
significantly increasing LRRK2 levels over time in both CTX tissue and CTX
cultures. The increase in vivo at P21 and in vitro at DIV21 occurs to a similar
extent, relative to P7 STD (∼5-fold). n = 3 Independent cultures ∗∗p < 0.01,
∗∗∗p < 0.001, ∗∗∗∗p < 0.0001 by ANOVA and Bonferroni post-test. (B) In lysate
from LRRK2 OEmouse CTX, LRRK2 protein is increased relative to NT
littermates at 1 month (∗p < 0.05 by ANOVA and Bonferroni post-test) and is
absent in knock-out mouse (KO) CTX. In CTX cultures from OEmice LRRK2
expression is∼3-fold increased over NT littermates at DIV14-21. (C) Production
of LRRK2 G2019S knock-in mouse model; Exon 41 of the endogenous murine
LRRK2 (NT, top) was replaced with G2019S-containing neomycin cassette
(middle), prior to cassette excision and retention of the loxP cut site (LRRK2
G2019S KI, bottom). Forward and reverse PCR primers (P1 and P2) were
designed to amplify the regions flanking the loxP site, resulting in a 307bp
fragment from NT endogenous LRRK2 and a 383bp fragment from each allele
of G2019S KI. (D) PCR products reveal clear separation between the predicted
band sizes and simple genotyping of NT, heterozygous (HET, herein KI) and
homozygous (Homo) KI mice (left). Examples of LRRK2 western blot of lysates
from three of the independent paired cultures (pooled KI and NT littermate
pups) used in all subsequent experiments. There are no significant differences
in the levels of LRRK2 protein in KI CTX cultures at DIV21.
PCR product in mutation-carrying mice, due to the residual loxP
site (Figures 1C,D). LRRK2 protein levels in cortical cell cul-
tures prepared from G2019S KI mice were comparable to NT
(Figure 1D, p = 0.5).
EXCITATORY SYNAPSE FUNCTION IN CORTICAL CULTURES FROM
LRRK2 KO AND OE MICE
We first assessed synaptic transmission in cortical cultures from
KO and OE mice by electrophysiological recording and analyses
of membrane properties and spontaneous activity in the form of
miniature excitatory post-synaptic currents (mEPSCs) at 21DIV.
There were no significant differences in intrinsic cell mem-
brane properties (capacitance, resistance and decay Tau, not
shown), nor were there any differences in mean event frequen-
cies or amplitudes in either KO or OE cortical cells, relative to
NT littermate cells (Figures 2A,B). The data indicate that total
membrane area and intrinsic excitability are unaltered and that
quantal charge (vesicular glutamate content), the number of
post-synaptic AMPA receptors and their sensitivity are equiva-
lent to NT, regardless of the loss or overexpression of LRRK2.
There were trends toward decreased and increased release fre-
quency in KO and OE cultures, respectively; however, the only
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FIGURE 2 | LRRK2 levels subtly alter excitatory transmission and
synaptic architecture. (A) Whole-cell patch-clamp recordings of neurons in
DIV21 CTX cultures from KO mice. (Top) Example traces of miniature
excitatory post-synaptic currents (mEPSCs) mediated by glutamatergic
AMPA-type glutamate receptors (AMPARs, left). Quantification of mean
mEPSC amplitude and frequency shows no significant difference between
genotypes (right). (Bottom) Cumulative probability analysis found no
significant differences in mEPSC amplitudes, but did detect a significant
interaction between inter-event intervals (IEIs) and genotype (2-way
RM-ANOVA ∗∗∗p ≤ 0.001), due to generally longer IEIs (indicative of lower
frequency) in KO neurons. (B) Example traces of mEPSCs in DIV21 CTX
cultures from OE mice (left). Quantification of mean mEPSC amplitude and
frequency shows no significant difference between genotypes (right).
(Bottom) Cumulative probability analysis found no significant differences in
mEPSC amplitues or IEIs in OE neurons. (C) Cultures were stained for
neuronal microtubules (MAP2, green) and excitatory pre-synaptic (VGluT1,
blue) and post-synaptic (PSD-95, red) markers for neuronal density and
synapse (VGluT1+PSD-95 co-clusters) measurements. Left: 40× imaging of
MAP staining (bar = 100um). Right: expanded ROI from 63× images of
synaptic markers overlayed with and without MAP2. Co-clusters (white
arrow heads) indicative of excitatory synapses are generally located
outside of the MAP2 dendritic microtubule scaffold, upon dendritic spines
that do not contain microtubules. (D,E) Both KO and OE neuronal densities
were similar to those of their respective NT littermate cultures (by MAP2
soma counts) as were their total dendritic areas (not shown). (D) Although
cluster intensities were significantly reduced in KO cultures (see text) and
they exhibited a trend toward fewer synapses, there were no significant
differences in the density or size of VGluT1 clusters, PSD-95 clusters or
co-clusters. (E) In OE neurons, there was no significant difference in
VGluT1 cluster density, despite a strong trend. There were significantly
more PSD95 clusters and synaptic co-clusters in OE neurons ∗p ≤ 0.05 by
Student’s t-test.
significant effect was a strong interaction between genotype and
inter-event interval by cumulative probability analysis in KO
cells. The data suggest that excitatory transmission is grossly
normal, regardless of the absence or overabundance of LRRK2
protein.
Event frequencies are used to infer differences in synaptic
probability of release (Pr) or synapse number, both of which may
be altered by cell density. Neither neuronal soma counts (MAP2
stained, Figures 2C–E), nor cell viability assays (not shown),
revealed any difference between KO or OE cultures, with respect
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to their NT controls. In order to conclude that a similar event fre-
quency is attributable to a similar Pr, synapse density must also
be determined. In cultures from KO mice, immunocytochemi-
cal staining to label pre-synaptic (vesicular glutamate transporter
1, VGluT1) and post-synaptic (post-synaptic density protein 95,
PSD-95) structures showed no significant change in the mean
dendritic density of either marker, or mean synapse density (esti-
mated by VGluT1+PSD-95 co-localization). Although the size
and density of VGluT1 and PSD-95 clusters was equivalent, we
found that the mean signal intensity of both markers was sig-
nificantly reduced in KO mice (VGluT1: NT = 0.21 ± 0.01
a.u., KO = 0.16 ± 0.01 a.u., p = 0.0026, MW U = 309. PSD-95:
NT = 0.14 ± 0.01 a.u., KO = 0.11 ± 0.01 a.u., p = 0.0001, MW
U = 163). Conversely, in OE cultures we observed a significant
increase in the density of PSD-95 clusters, relative to NT con-
trols, that was accompanied by a significant increase (17.6%) in
synapse density (p = 0.017, Figures 2C–E) but no alteration to
signal intensity.
Together, the data demonstrate that constitutive loss of LRRK2
does not prevent neuronal survival or synaptic network matu-
ration, but does result in subtle negative alterations to synaptic
proteins and release probability. Furthermore, the 2–3 fold over-
expression of human wild-type LRRK2 had no marked effect
upon neuronal survival or synaptic network maturation but did
produce an increase in excitatory synapse density in 3-week-old
cortical neurons.
INCREASED SYNAPTIC TRANSMISSION G2019S KNOCK-IN MOUSE
CULTURES
The data suggest that chronic loss of LRRK2 function induces only
modest negative effects upon glutamate synapses, and that LRRK2
overexpression produces an increase in synapse connectivity. This
information provides the requisite foundation against which to
infer gain- or loss-of function effects in PD mutants, which was
the primary goal of this study. To investigate the specific effects
of LRRK2 mutations we prepared cortical cultures from G2019S
knock-in mice (Figures 1C,D) that carry the most common
disease-linked mutation in the endogenous murine protein under
appropriate expression patterns and levels (Figures 1C,D).
Unlike KO or OE cells, the intrinsic cell membrane proper-
ties of DIV21 cortical cells from KI mice and littermate controls
exhibited some modest differences; membrane resistances were
not significantly different (p = 0.96) but membrane capacitance
trended toward being increased in KI cells (Cm: NT 86.7 ±
4.9, KI 100 ± 5.0, p = 0.06) and membrane decay Tau was
significantly slower (by non-parametric, but not by paramet-
ric Student’s t-test. Tm: NT 1.6 ± 0.1, KI 1.9 ± 0.1, Mann
Whitney p = 0.03). Analysis of mEPSCs demonstrated no dif-
ference in the mean amplitude of events (Figures 3A,B), but
there was a significant increase (36.5%) in the mean frequency
of excitatory transmission onto KI cortical cells, relative to NT
littermate cells (p = 0.007, 21.06 ± 2.1 and 13.37 ± 1.8Hz,
respectively, Figures 3A,B). To further examine differences in
mEPSCs between KI cortical cells and those from littermates,
cumulative probability analysis was conducted for each cell and
genotype means generated (Figure 3C). By 2-way RM-ANOVA,
there was no main effect of genotype, nor was there a significant
interaction between genotype and event amplitude (Figure 3C,
right); however, as predicted from increased KI mean frequency,
there was a highly significant main effect of genotype upon
mEPSC inter-event intervals and interaction between genotype
and frequency (Figure 3C, right). The results suggest excitatory
transmission is significantly increased by the G2019S mutation in
cortical neurons.
To determine whether increased frequency in KI culture is
a result of either elevated Pr or increased synapse density, cell
counts and synaptic staining was performed (Figures 3D,E).
There were no significant differences in cell density, VGluT1 or
PSD-95 cluster densities or excitatory synapse density in cultures
from KI mice (relative to NT controls). Thus, the data demon-
strate that increased excitatory synaptic event frequency in KI
mice is likely due to increased Pr at a similar number of synapses.
To determine whether increases in synaptic release were spe-
cific to glutamatergic synapses, we stained cultures for the
pre-synaptic protein synapsin 1 (present at both glutamater-
gic and GABAergic terminals) and recorded GABAergic minia-
ture inhibitory post-synaptic currents (mIPSCs, Figures 3E–H).
There were no significant differences in the number (or inten-
sity; not shown) of synapsin 1 clusters in cultured KI neu-
rons (Figure 3E, right), nor were there significant differences
in cell mean mIPSC amplitudes and frequencies (Figures 3F,G).
Cumulative probability analysis demonstrated no main genotype
effect upon either mIPSC amplitudes or inter-event intervals,
despite a strong trend in both (Figure 3H). There was a highly
significant interaction between genotype and mIPSC amplitude.
The data demonstrate that there may be subtle alterations to
inhibitory synaptic transmission induced by physiological levels
of the G2019S mutation, but also that excitatory synaptic release
appears to be particularly sensitive to the PD associated mutation
in KI mouse cortical cells.
DECREASED PHOSPHORYLATION OF SYNAPSIN 1
Evidence shows LRRK2 binds several pre-synaptic release regula-
tory proteins including synapsin 1, VAMP2, dynamin 1 and Endo
A (Piccoli et al., 2011, 2014; Cirnaru et al., 2014; Stafa et al., 2014)
and LRRK2 kinase activity regulates the phosphorylation state of
EndoA that is required for efficient endocytic vesicle formation
and maintenance of repeated release events (Matta et al., 2012).
We probed the same cortical neuronal cultures as those used for
electrophysiological and immunocytochemical experiments for
numerous pre-synaptic proteins by standard Western blotting.
Protein expression levels were similar between genotypes by semi-
quantitative western blot (relative to GAPDH, Figures 4A,B); by
paired t-test there were no significant differences between NT lit-
termate and KI cultures in the levels of EndoA (NT = 1.00 ±
0.11, KI = 0.98 ± 0.11, p = 0.69), VAMP1 (NT = 1.00 ± 0.22,
KI = 0.98 ± 0.19, p = 0.90), VAMP2 (NT = 1.00 ± 0.14, KI =
0.90 ± 0.06, p = 0.30), synaptojanin 1 (NT = 1.00 ± 0.15 and
KI = 0.95 ± 0.16, p = 0.72), dynamin 1 (NT = 1.00 ± 0.07 and
KI = 1.05 ± 0.14, p = 0.37) or synapsin 1 (NT = 1.00 ± 0.31
and KI = 1.31 ± 0.39, p = 0.24, Figure 4B).
Synapsins are among the most abundant regulatory synap-
tic vesicle phosphoproteins, and their function is regulated by
kinase and phosphatase activity (Jovanovic et al., 2001; Hojjati
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FIGURE 3 | Increased excitatory transmission and altered GABA
currents in G2019S KI cortical neurons. (A-C) Whole-cell patch-clamp
recordings of neurons in DIV21 CTX cultures from KI mice. (A) Example
traces of mEPSCs. (B) Quantification of mean mEPSC amplitude and
frequency shows no significant difference in amplitude, but significantly
higher frequency of events in KI neurons (∗∗p ≤ 0.01 by Student’s t-test).
(C) Cumulative probability analysis found no significant differences in
mEPSC amplitudes, but revealed a significant main effect of genotype and
interaction between IEI and genotype (2-way RM-ANOVA, ∗∗p ≤ 0.01,
∗∗∗∗p ≤ 0.0001, values between 40 and 200ms were also significant by
Bonferroni post-test ∗∗∗p ≤ 0.001), due to shorter IEIs (indicative of higher
frequency) in KI neurons. (D) Cultures were stained (as in Figure 2) for
MAP2 (green) and VGluT1 (blue) and PSD-95 (red). Left: 60× 2-times zoom
of individual neuron staining. Right: expanded ROI from the 63× image
showing synaptic markers overlayed with and without MAP2. Co-clusters
are highlighted (white arrow heads). (E) KI neuronal densities were similar
to those of NT littermates as were total dendritic areas (not shown), there
were no differences (or trends) in the density of VGluT1 clusters, PSD-95
clusters or co-clusters (glutamate synapses). Similarly there were no
differences in the density, size or intensity of synapsin 1 (Syn1) clusters,
present at all glutamatergic and inhibitory synapses. (F) Example traces of
miniature inhibitory post-synaptic currents (mIPSCs). (G) Quantification of
mean mIPSC amplitude and frequency shows trends, but no significant
differences in event amplitude or frequency of events in KI neurons. (H)
Cumulative probability analysis revealed a highly significant interaction (and
nearly significant genotype effect) due to increased mIPSC amplitudes in
KI neurons (2-way RM-ANOVA, ∗∗∗∗p ≤ 0.0001, values between 25 and
35pA were significant by Bonferroni post-test ∗∗p ≤ 0.01). There was no
significant main effect of genotype on mIPSC IEIs or interaction (despite a
trend to higher frequency) in KI neurons.
et al., 2007; Valente et al., 2012). By standard semi-quantitative
western blot, we probed for phosphorylated synapsin 1 (pSyn1)
with S9 (site 1) and S603 (site 3) phospho-selective antibodies,
and found that the relative levels of phosphorylation at both of
these sites was significantly reduced in cortical cultures from KI
mice, with respect to NT controls (Figure 4B). Within genotype,
Syn1a and Syn1b levels were similar, as were the total and rela-
tive phosphorylation levels; in light of this only total Syn1 (a+b)
is presented. Reductions in pSyn1, while significant at both sites
in KI mice, were derived from standard semi-quantitative western
blotting, which suffers from a relatively high degree of variability
both between and within sample runs, likely due to minor incon-
sistencies in liquid handling, sample transfer and human error.
In order to confirm reductions in pSyn1 ratios, we ran a subset of
KI samples through aWes size-separation (ProteinSimple©) assay.
This technology uses an automated capillary-based separation
process that removes many manual and technical manipulations,
including transfer, eliminating much variability and providing
direct protein quantification. Clear separation of GAPDH, and
Syn1a and b were achieved within each capillary (representative
band analysis in Figure 4C) and quantification (Figure 4D) con-
firmed the results of the standard blotting; Syn1 a and b levels
were equivalent, but the ratio of pS603 Syn1 was significantly
reduced in KI neurons, relative to NT littermate cultures.
Together the data demonstrate that synaptic activity and pro-
tein regulators of vesicle release are altered by the presence of
physiological levels of the LRRK2G2019Smutation in 3-week-old
mammalian neurons.
DISCUSSION
LRRK2 AND REGULATION OF SYNAPTIC FUNCTION IN VITRO
The chronic loss of LRRK2 in KOmouse cortical cultures resulted
in only a subtle reduction in glutamatergic transmission at a sim-
ilar density of synapses at 21 days in vitro. Although synaptic
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FIGURE 4 | Reduced Synapsin 1 phosphorylation in KI cortical
neurons. Levels of pre-synaptic proteins in DIV21 CTX cultures were
assayed by standard western blotting and verified via WES automated
capillary-based size sorting system. (A) Representative western blots of
EndophilinA (EndoA), vesicle associated membrane protein 1 (VAMP1),
vesicle associated membrane protein 2 (VAMP2), dynamin 1, synapsin1
(Syn1), phosphoserine 9 synapsin1 (pS9 Syn1), and phosphoserine 603
synapsin1 (pS603 Syn1). (B) Quantification of synapsin1 levels and
associated phosphorylation sites. Synapsin1 levels were similar between
NT and KI however the ratio of phosphorylated synapsin1 was
significantly reduced at both sites. (C) Standard western blot results
were verified using the WES automated capillary-based size sorting
system for the S603 phosphorylation site. Representative pseudo-gels
(left) and electropherograms (right) exported from the WES compass
analysis software. (D) Quantification of synapsin1 and pS603 synapsin1
confirmed significant reductions pS603 synapsin1. Data expressed
relative to GAPDH and normalized to NT, ∗p ≤ 0.05 ∗∗p ≤ 0.01 by paired
Student’s t-test.
cluster densities were unaltered in KO cells, there was a marked
general reduction in both VGluT1 and PSD95 signal intensity,
which may reflect reduced synaptic protein levels. In light of this,
a harsh image threshold would produce a reduction in the den-
sity of both markers and synapses in KOs, but careful (blinded)
thresholding demonstrated that the size and density of synapses
is equivalent in NT and KO cells. KOs cells have been shown to
have (at least at some point in development) longer dendrites
(MacLeod et al., 2006; Parisiadou et al., 2009; Dachsel et al.,
2010; Sepulveda et al., 2013). If they were similarly longer in
this study, with equivalent synapse densities, elevations in total
synapse number might be predicted to result in an increased
event frequency. The opposite trend was observed here in KO
cells. Together, the data provide further evidence that LRRK2 acts
at glutamatergic synapses in mammalian neurons (Piccoli et al.,
2011; Parisiadou et al., 2014) and, along with recent Drosophila
studies (Lee et al., 2010; Matta et al., 2012), strengthens the case
for LRRK2s role in the regulation of synaptic release machinery.
That said, understanding the experimental and synaptic context
of LRRK2 manipulations is crucial to attempts at extrapolating
its physiological role, as both increases (Piccoli et al., 2011) and
decreases (Matta et al., 2012; Parisiadou et al., 2014) in synaptic
activity have been observed following LRRK2 loss of function in
different systems.
Increasing LRRK2 levels 2–3 fold resulted in an increase in
the density of synaptic markers and synapse numbers. There
were non-significant trends toward increased event frequency and
reduced inter-event intervals that may reflect the ∼17% increase
in synapse density. Alternatively, homeostatic compensation may
mask the increased synapse density by reducing probability of
release at a greater number of synapses. This is in agreement with
a lack of effect observed in DA cell degeneration in Drosophila
(Lee et al., 2007); however, overexpression has been shown to
decrease pre-synaptic bouton numbers (Lee et al., 2010) and have
exactly the same effect as LRRK2 loss of function on synap-
tic release in Drosophila (Matta et al., 2012). Together the data
strongly suggest that the synaptic consequences of LRRK2manip-
ulations may be model-, cell- and context-dependent; thus it
may be of paramount importance to determine the compara-
tive effects of knock-out, overexpression and mutation within the
same system to enable interpretation of the results.
PHYSIOLOGICAL LEVELS OF G2019S LRRK2 INCREASE GLUTAMATE
RELEASE AND ALTER PRE-SYNAPTIC FUNCTION
Examination of overexpression and knock-out of LRRK2 in our
primary cortical cultures provided the platform against which to
compare the effects of mutant LRRK2. We observed a marked
∼37% increase in the frequency of glutamate excitatory currents
in G2019S KI cultures, in the absence of any change to synapse
density. Importantly, this demonstrated that the LRRK2 muta-
tion produces effects that are distinct from those of simple loss-of
function or gain-of-function. We did detect a (non-significant)
13% increase in KI membrane capacitance that could be pre-
dictive of increased dendritic membrane area, longer dendrites
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and more numerous (equally dense) synapses. However, cor-
relation analysis between membrane capacitance and mEPSC
event frequency in KI cells showed absolutely no relationship
(Pearson’s R = 0.002, P = 0.99), whereas there was a significant
positive correlation in NT cells (R = 0.49, P = 0.007). We take
this as evidence that the increase in KI frequency is indepen-
dent of potential difference in total dendrite length especially
as it supersedes the usual correlation—i.e. smaller cells with
similar synapse densities also have high event frequency, pre-
sumably from overactive pre-synaptic elements. Also, there is
consensus from several studies that wild-type overexpression and
mutant overexpression both result in shortened dendritic length
(MacLeod et al., 2006; Parisiadou et al., 2009; Dachsel et al., 2010;
Ramonet et al., 2011; Winner et al., 2011; Sepulveda et al., 2013).
If OE and KI cells here also have shortened dendrites, with equal
synapse densities, then total synapse number would be reduced.
Consequently the observed increase in KI event frequency would
be an underestimate for increased Pr.
There was also a significant slowing of membrane responses to
direct current injection in KI cells, which correlated with signifi-
cantly slower mEPSCs rise times. This, in concert with trends in
capacitance values, suggests altered intrinsic membrane proper-
ties that are likely related and may be explored in future studies.
However, like capacitance, there was no significant correlation
between mEPSC rise time and event frequency in either NT
(R = 0.1, p = 0.09) or KI cells (R = 0.004, p = 0.7), arguing that
post-synaptic membrane alterations do not account for increased
transmission. It appears that a single copy of G2019S LRRK2 is
sufficient to dramatically alter excitatory synaptic release, in a
manner distinct from a loss of LRRK2 and in excess of any changes
produced by a 3-fold increase in LRRK2 levels.
The G2019S mutation resides in LRRK2’s kinase domain, and
has been shown to augment LRRK2 kinase activity in vitro,
demonstrating a gain-of-function for LRRK2 autophosporylation
and phosphorylation of a generic substrate (West et al., 2005;
Nichols et al., 2010). This has led to a major push for iden-
tification of LRRK2 substrates and the development of kinase
inhibitors as they may offer therapeutic potential (Webber et al.,
2011). The list of candidate substrates is growing, and includes
Tau (Kawakami et al., 2012; Bailey et al., 2013), 4E-BP (Lee
et al., 2010), and EndoA (Matta et al., 2012). Unfortunately,
interpretation of many of these findings is hampered by bind-
ing relationships potentially forced in vitro by non-physiological
concentrations of substrate and enzyme (Webber et al., 2011),
failure of supporting evidence in vivo (Trancikova et al., 2012)
and reliance on inhibitors that exhibit off-target and/or sys-
temic effects (Drolet et al., 2011; Cirnaru et al., 2014; Luerman
et al., 2014) even in LRRK2 knock-out cells. That said, it is
clear that many of the proposed LRRK2 interactors and sub-
strates are directly linked to the synaptic vesicle cycle, notably
syntaxin 1A, dynamin1, synapsin1 and VAMP2 (Piccoli et al.,
2014) and EndoA; phosphorylation of EndoA by LRRK2 has
been demonstrated to regulate transmitter release (Matta et al.,
2012). If the cause of increased release is as simple as the ∼3-
fold increase in LRRK2 kinase activity (West et al., 2005; Nichols
et al., 2010), other factors must be at play to account for synaptic
alterations in KI mouse cells well above those seen in OE cultures
(expressing 3-fold more LRRK2) and preferential effects upon
glutamatergic, rather than GABAergic release. LRRK2 localiza-
tion and kinase activity are regulated by its own phosphorylation
state and through dimerization by co-chaperone 14-3-3 (Sen
et al., 2009; Nichols et al., 2010; Rudenko and Cookson, 2010);
thus greater effects may be engendered by G2019S upon kinase
activity in living neuronal systems under appropriate regulation.
We assayed the protein levels of several interactors but found
none to be significantly altered. The phosphorylation state of
vesicle cycle regulators has direct consequences for their activ-
ity and we sought to assay the phosphorylation status of EndoA,
pertinent to LRRK2 activity and vesicle release in Drosophila
(Matta et al., 2012); unfortunately, the only phosphoantibody
currently specific to the pertinent EndoA serine 75 site is inef-
fective in mammalian tissue (personal communication, Dr. Patrik
Verstreken).We therefore turned our attention to reasonably well-
characterized phosphorylation sites on synapsin 1, one of the
most abundant of all pre-synaptic vesicle proteins.
Synapsins are believed to regulate the balance between the
reserve and the readily releasable (docked) vesicle pools and act
as modulators of vesicle exocytosis (Fdez and Hilfiker, 2006). It
has been suggested that phosphorylated synapsin 1 binds vesi-
cles and tethers them to the actin cytoskeleton for retention in
the reserve pool; thus, phospho-synapsin 1 reduces the num-
ber of vesicles available for release from the readily releasable
pool, whereas dephosphorylated synapsin dissociates from vesi-
cles, thereby freeing them to dock for ready release (Hosaka
et al., 1999). However, this supposition is not universally sup-
ported; some reports describe synapsin depletion when vesicles
undergo active zone docking (Pieribone et al., 1995) but oth-
ers show that synapsins remain associated with vesicles during
exo- and endocytosis (Torri-Tarelli et al., 1990). Furthermore,
with several studies showing the mature vesicle cluster contains
virtually no cytoskeleton, the original hypothesis is unlikely to
explain synapsin function there (reviewed in Sudhof, 2004; Fdez
and Hilfiker, 2006). Although the mechanism by which synapsin
1 regulates vesicle release remains elusive, synapsin 1 phosphory-
lation states are indicative of pre-synaptic regulation and release
activity (reviewed in Sudhof, 2004; Fdez and Hilfiker, 2006;
Valente et al., 2012; Verstegen et al., 2014). In KI cortical cultures
that exhibited a marked increase in synaptic release, we found
a clear reduction in synapsin 1 phosphorylation at both S6 and
S603 by traditional western blot and confirmed reduced pS603 by
proteinsimpleWes size separation.
It is interesting to note that we observed significant effects
upon glutamate frequency and significant effects upon GABA
amplitudes. An increase in excitatory synaptic transmission
across the neuronal network in the culture might be predicted
to alter the GABAergic inhibitory neurons within it and subse-
quently the post-synaptic responsiveness to their activity (Wang
and Maffei, 2014). Homeostatic mechanisms may also exag-
gerate GABAergic inhibition, in order to counteract the effects
of increased glutamate release (Shepherd et al., 2006; Maffei
and Fontanini, 2009), but network interactions are very hard
to predict or interpret. This dichotomy may even be explained
by alterations to synapsin 1, as it has been shown that neu-
rons in cortical cultures prepared from synapsin 1 null mice
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exhibit opposite changes to glutamate and GABA transmission
(Chiappalone et al., 2009).
The S603 site is a specific target of CaMKII and, predictably,
synapsin 1 pS603 is reduced by∼70% in CaMKII knock-out mice
(Hojjati et al., 2007). In support of our link between reduced
pS603 and increased release, CaMKII knock-out mice have an
increased probability of release (Silva et al., 1992; Hinds et al.,
2003), significantly more docked vesicles and a reduced propen-
sity to synaptic fatigue (Hojjati et al., 2007). Probing the similarity
between LRRK2 G2019S KI mice and CaMKII knock-outs may
prove interesting in future studies.
SUMMARY AND CONCLUSIONS
Together, the evidence collected here in cortical cultures from
KO, OE and KI mice demonstrates that LRRK2 has an influ-
ence on pre-synaptic function, likely through regulation of pre-
synaptic regulatory proteins. The challenge is to clarify which
specific functions of LRRK2 go awry in G2019S mutants, and
how this eventually leads to parkinsonism. The data compliment
and extend the contemporary literature (Piccoli et al., 2011;Matta
et al., 2012; Parisiadou et al., 2014) by providing evidence in sup-
port of a role for LRRK2 in synaptic transmission and a clear
gain-of-function effect of the G2019Smutation. Furthermore, the
increases in synaptic release in G2019S KI mice are distinct from,
or in excess of, those produced by a 3-fold increase in LRRK2
protein levels (in OE mice).
Our data also show that the loss of LRRK2 is tolerated in
3-week-old neuronal cultures and the brain, as predicted from
viable, generally healthy LRRK2 KO mice (Hinkle et al., 2012).
Therefore, it seems likely that LRRK2 exhibits a high degree of
functional redundancy in the central nervous system (CNS) and
that loss-of-function effects are unlikely to underlie PD pathogen-
esis. In light of this, CNS-specific silencing of LRRK2may present
a viable therapeutic target.
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